Back to results
US 2023/0398135 A1Published application
Compositions including cannabinoid and use thereof in the manufacture of a medicament for the treatment of inflammation in a subject
AssigneeAngrow Company Limited
InventorsDengfeng YANG, Chunfeng CHAI, Xuan TAN
Life of this patent
Estimating the term…
Abstract
Compositions including cannabinoid and use thereof are provided in the present disclosure. In some embodiments, the composition may include cannabidiol (CBD), cannabigerol (CBG), and bakuchiol (BAK). A molar concentration ratio of CBD, CBG, and BAK may be 1:1:1 in the composition. A molar concentration of CBD in the composition may be in a range of 1.67 μM to 16.7 μM.
Claims23
A composition, comprising:
- cannabidiol (CBD), cannabigerol (CBG), and bakuchiol (BAK), wherein a molar concentration ratio of CBD, CBG, and BAK is 1:1:1 in the composition, and a molar concentration of CBD in the composition is in a range of 1.67 μM to 16.7 μM.
(canceled)
(canceled)
14-20. (canceled)
A composition, comprising:
- cannabidiol (CBD), cannabigerol (CBG), and bakuchiol (BAK), wherein
- a molar concentration of CBD in the composition is in a range of 1.67 μM to 16.7 μM;
- a total CBD/CBG/BAK molar concentration of the composition is in a range of 5 μM to 50 μM, the total CBD/CBG/BAK molar concentration of the composition being defined by a sum of molar concentrations of CBD, CBG, and BAK in the composition;
- and
- the composition has a synergistic anti-inflammatory effect or an additive anti-inflammatory effect.
2 more elements
A composition, comprising:
- cannabidiol (CBD), cannabigerol (CBG), and bakuchiol (BAK), wherein
- a molar concentration ratio of CBD, CBG, and BAK is 1:1:1 in the composition;
- a molar concentration of CBD in the composition is in a range of 1.67 μM to 16.7 μM;
- the composition has a synergistic anti-inflammatory effect at a first total CBD/CBG/BAK molar concentration, a combination index of CBD, CBG, and BAK in the composition corresponding to the first total CBD/CBG/BAK molar concentration being less than 1;
- and
- the composition has an additive anti-inflammatory effect at a second total CBD/CBG/BAK molar concentration, wherein:
- the second total CBD/CBG/BAK molar concentration is greater than the first total CBD/CBG/BAK molar concentration.
4 more elements
Dependencies are inferred from the claim text.